| Name | Title | Contact Details |
|---|
Stemgent Inc is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Evanston Regional Hospital is your community healthcare provider; a 42-bed facility with complete inpatient and outpatient care. We believe in the power of people to create great care. We`re more than 50 healthcare professionals strong. We are a Joint Commission accredited facility. And we work hard every day to be a place of healing, caring and connection for patients and families in the community we call home.
CareJourney is a leading provider of clinically-relevant analytics for value-based networks. Headquartered in Arlington, VA, CareJourney currently supports leading payer, provider, and life sciences organizations across the US in achieving their goals by wringing new, high value insights out of expansive population claims data. Through its CareJourney Platform, CareJourney provides members with interactive dashboards of clinically-relevant insights around network design and management, care model management, patient risk segmentation, spend and utilization trends, network integrity, low-value care, and provider, practice and facility (acute and post-acute) performance.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
SolutionHealth is a new, regional healthcare system comprised of Elliot Health System and Southern New Hampshire Health. SolutionHealth allows both Elliot Health System and Southern New Hampshire Health to be even better together by pursuing actionable strategies to improve the health of our communities with collaborations that improve access to high quality, high value care delivered locally.